Biotech company Senti Bio to go public via $600m SPAC deal

Biotech company Senti Bio to go public via $600m SPAC deal

Biotechnology company Senti Biosciences Inc has agreed to go public through a merger with blank-check firm Dynamics Special Purpose Corp in a deal that values the combined company at $601 million. Senti, short for “sentient”, uses a gene circuit technology platform...
Abry Partners sells Edgile stake to Wipro for $230m

Abry Partners sells Edgile stake to Wipro for $230m

Wipro on Monday said it will acquire Austin, Texas-headquartered Edgile for $230 million, a move that will strengthen the IT major’s play in the cybersecurity services space. Edgile’s experienced cybersecurity and risk management professionals will allow Wipro to...
Oaktree SPAC to Merge With Pharma Company in $2bn Deal

Oaktree SPAC to Merge With Pharma Company in $2bn Deal

Oaktree Acquisition Corp. II will merge with Alvotech Holdings, a global biopharmaceutical company, to take the company public in the United States. The deal values the combined company at about $2.25bn, including debt. The downtown-based blank check company is a...